On Invalid Date, Myomo (NYSEMKT: MYO) reported Q2 2023 earnings per share (EPS) of -$0.04, up 90.48% year over year. Total Myomo earnings for the quarter were -$1.01 million. In the same quarter last year, Myomo's earnings per share (EPS) was -$0.42.
On Invalid Date, Myomo (NYSEMKT: MYO) reported Q2 2023 revenue of $5.96 million up 62.02% year over year. In the same quarter last year, Myomo's revenue was $3.68 million.
What was MYO's revenue growth in the past year?
As of Q3 2023, Myomo's revenue has grown 9.11% year over year. This is 3.24 percentage points higher than the US Medical Devices industry revenue growth rate of 5.87%. Myomo's revenue in the past year totalled $17.41 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.